AN2 Therapeutics, Inc. (ANTX) Q1 2025 Earnings
ANTX·Reported May 13, 2025·Before market open
Diluted EPS came in at $-0.35 (+37.5% YoY), missed the $-0.26 consensus by $0.09.
Diluted EPS
$-0.35missed by $0.09
Consensus: $-0.26
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about AN2 Therapeutics, Inc.'s Q1 2025 earnings report.
AN2 Therapeutics, Inc. (ANTX) reported Q1 2025 earnings on May 13, 2025 before market open.
AN2 Therapeutics, Inc. reported diluted EPS of $-0.35 for Q1 2025.
EPS missed the consensus estimate of $-0.26 by $0.09.
Compared to the same quarter a year prior, diluted EPS grew 37.5% from $-0.56.
You can read the 10-Q periodic report (0000950170-25-070358) directly on SEC EDGAR. The filing index links above go to sec.gov.